MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617086010 A) filed by Shanghai Argo Biopharmaceutical Co. , Ltd. on July 14, 2026, for Compositions And Methods For Inhibiting Expression Of Inhibin Subunit Beta E (inhbe).
Inventors include Shu, Dongxu; Shao, Pengcheng Patrick; and Xia, Shiwei.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: Compositions and methods useful to reduce expression of INHBE gene and for treatment of INHBE-associated diseases and conditions are provided. Provided are INHBE dsRNA agents, INHBE antisense polynucleotide agents, compositions comprising INHBE dsRNA agents, and compositions comprising INHBE antisense polynucleotide agents that can be used to reduce INHBE expression in cells and subjects.
Disclaimer: Curated by HT Syndication.
